1 |
Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms |
J Clin Invest |
2002 |
15.9 |
391 |
2 |
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice |
J Clin Invest |
2000 |
15.9 |
348 |
3 |
Inflammation and cellular immune responses in abdominal aortic aneurysms |
Arterioscler Thromb Vasc Biol |
2006 |
8.7 |
296 |
4 |
Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms |
J Clin Invest |
2000 |
15.9 |
268 |
5 |
Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm |
Arterioscler Thromb Vasc Biol |
1995 |
8.7 |
256 |
6 |
Pathophysiology and epidemiology of abdominal aortic aneurysms |
Nat Rev Cardiol |
2011 |
49.6 |
226 |
7 |
Abdominal aortic aneurysm |
Lancet |
2005 |
168.9 |
216 |
8 |
Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm |
Arterioscler Thromb Vasc Biol |
1997 |
8.7 |
176 |
9 |
Abdominal aortic aneurysm: pathogenesis and implications for management |
Arterioscler Thromb Vasc Biol |
2006 |
8.7 |
176 |
10 |
Mouse models of abdominal aortic aneurysms |
Arterioscler Thromb Vasc Biol |
2004 |
8.7 |
174 |